You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 10, October 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cataracts in a Patient With Vitiligo Who Received Photochemotherapy

Anita Pedvis-Leftick, MD; Marshall N. Cyrlin, MD; Lawrence M. Solomon, MD

Arch Dermatol. 1979;115(10):1253-1254.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Vitiligo is an acquired localized or generalized total loss of pigment secondary to loss of melanocytes. Its cause is unknown. In 1947, El Mofty1 introduced the use of methoxsalen for the treatment of vitiligo. Parrish et al2 described the use of psoralens in combination with high-intensity long ultraviolet wavelengths (UV-A) as an effective treatment for vitiligo. The UV-A-induced cataract formation has been reported in animals,3,4 but not in humans. The following is a report of cataracts found in a patient who received photochemotherapy for vitiligo.

Report of a Case

In early 1976, progressive depigmentation of both hands developed in a 42-year-old black woman. There had been no contact with phenolic compounds or history of alopecia, cataracts, vitiligo, diabetes, or thyroid disease. The patient had no history of ophthalmologic disease. She did not have an ophthalmologic examination at that time. The hemoglobin level was 11.2 g/dL, with normal . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Dermatology, Abraham Lincoln School, University of Illinois at the Medical Center (Drs Pedvis-Leftick and Solomon), and the Department of Ophthalmology, University of Illinois Eye and Ear Infirmary (Dr Cyrlin), Chicago.


Footnotes

Reprint requests to the Department of Dermatology, Abraham Lincoln School of Medicine, PO Box 6998, Chicago, IL 60680 (Dr Pedvis-Leftick).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.